Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hui Ti See
Observed names:
H T See,
H. See,
H. T. See,
H.T See,
H.T. SEE,
H.T. See,
Hui T. See,
Hui Ti SEE
show all 8
Institutions:
Mount Elizabeth Hospital,
Parkway Cancer Centre
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Mount Elizabeth Hospital,
Gleneagles Hospital,
National Cancer Center,
National Cancer Centre Singapore,
Parkway Cancer Centre
show all 6
OpenAlex ID:
A5113714959
Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009
2009
·
Siriwan Tangjitgamol
, Benjamin O Anderson
, et al.
·
The Lancet Oncology
·
68
Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study
2005
·
S. TANGJITGAMOL
, P.T. RAMIREZ
, et al.
·
International Journal of Gynecological Cancer
·
56
Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance
2005
·
H.T. See
, R.S. Freedman
, et al.
·
International Journal of Gynecological Cancer
·
54
Targeted therapy for epithelial ovarian cancer: Current status and future prospects
2003
·
H. T. See
, J. J. Kavanagh
, et al.
·
International Journal of Gynecological Cancer
·
50
Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer
2006
·
H.T. SEE
, D.A. THOMAS
, et al.
·
International Journal of Gynecological Cancer
·
24
Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed mullerian tumors of the uterus
2006
·
L. WONG
, H.T. SEE
, et al.
·
International Journal of Gynecological Cancer
·
22
Adjuvant Chemotherapy for Endometrial Cancer
2011
·
Siriwan Tangjitgamol
, Hui Ti See
, et al.
·
International Journal of Gynecological Cancer
·
21
Triple-negative metastatic/recurrent breast cancer: Treatment with paclitaxel/carboplatin combination chemotherapy
2007
·
J. W. Chia
, P. Ang
, et al.
·
Journal of Clinical Oncology
·
18
Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients
2004
·
S. Tangjitgamol
, H. T. See
, et al.
·
International Journal of Gynecological Cancer
·
13
Attitudes towards cancer survivors: a small survey.
2006
·
H M K Chen
, W H Tan
, et al.
·
PubMed
·
12
Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients
2004
·
S. Tangjitgamol
, H.T. See
, et al.
·
International Journal of Gynecological Cancer
·
6
Gestational Trophoblastic Disease
2006
·
Hui T. See
, Ralph S. Freedman
, et al.
·
Springer eBooks
·
4
Multimodality treatment for stage III non small cell lung cancer
2000
·
K.F Foo
, E.H Tan
, et al.
·
Lung Cancer
·
4
O-53 A randomized phase II trial of gemcitabine, vinorelbine or docetaxel in the treatment of elderly and/or poor performance state patients with non-small cell lung cance (NSCLC)
2003
·
Swan Swan Leong
, Kian Fong Fool
, et al.
·
Lung Cancer
·
3
222 Expression of HER-2/NEU, Epidermal Growth Factor Receptor, Vascular Endothelial Growth Factor, Cyclooxygenase-2, Estrogen Receptor, and Progesterone Receptor in Small Cell and Large Cell Neuroendocrine Carcinoma of The Uterine Cervix: A Clinicopathologic and Prognostic Study
2004
·
S. Tangjitgamol
, P.T. Ramirez
, et al.
·
International Journal of Gynecological Cancer
·
1
Efficacy and Tolerability of Irinotecan in Patients with Advanced Colorectal Cancer in Singapore
2002
·
H T See
, W H Koo
, et al.
·
Annals of the Academy of Medicine Singapore
·
1
100P Comprehensive genomic landscape of Asian and African breast cancer (BC) patients (pts)
2025
·
V.Y.M. Heong
, J.Y.S. Chan
, et al.
·
ESMO Open
PDF
Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy.
2020
·
Jing Shan Lim
, Yukti Choudhury
, et al.
·
Journal of Clinical Oncology
2086 POSTER Clinical implications of the MDR1 1236C>T polymorphism: influences on doxorubicin pharmacokinetics and myelosupression in Asian breast cancer patients
2007
·
Z.W. Wong
, S. Lal
, et al.
·
European Journal of Cancer Supplements
Carcinosarcoma of the uterus: A comparison of adjuvant therapy and outcome
2006
·
Lisa WONG
, Hui Ti SEE
, et al.
·
Asia-Pacific Journal of Clinical Oncology
P120 Ethnic differences in patients presenting at a more advanced stage of breast cancer in Singapore — a single institution experience
2005
·
P. Ang
, H. See
, et al.
·
The Breast
Metastatic Cancer of Unknown Primary
2004
·
Hui Ti See
, Sandeep Kumar Rajan
·
WORLD SCIENTIFIC eBooks
719 Third-Line Chemotherapy in Platinum- and Paclitaxel-Resistant Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma Patients
2004
·
S. Tangjitgamol
, H.T. See
, et al.
·
International Journal of Gynecological Cancer
P-67 Characteristics of lung cancer patients referred to the Department of Medical Oncology, National Cancer Centre, Singapore
2003
·
Chee Keong Toh
, Swan Swan Leong
, et al.
·
Lung Cancer
P-75 Do smokers and non-smokers with non-small cell lung cancer have biologically different disease?
2003
·
Chee Keong Toh
, Swan Swan Leong
, et al.
·
Lung Cancer
Show more works
View as search
Works count:
27
Citation count:
357
H-index:
10
I10-index:
10
Year
Topic
Type